Related Experiment Video
Updated: Mar 26, 2026
04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
10.3K
[What's new in internal medicine?]
1INSERM, U1016, institut Cochin, Paris, France; CNRS, UMR8104, Paris, France; Université Paris-Descartes, Sorbonne-Paris- Cité, Paris, France; Université Paris-Descartes, faculté de médecine, pôle de médecine interne, centre de référence pour les vascularites nécrosantes et la sclérodermie systémique, hôpital Cochin, Assistance publique-hôpitaux de Paris, Paris, France; Service de Médecine Interne, hôpital Cochin, 27, rue du Faubourg-Saint- Jacques, 75014, Paris, France.
Annales De Dermatologie Et De Venereologie
|January 22, 2016
Summary
This review covers recent clinical advances in autoimmune, inflammatory, and systemic diseases, focusing on new classifications and trial results for conditions like lupus and vasculitis.
Area of Science:
- Dermatology and Immunology
- Internal Medicine
- Clinical Research
Context:
- Highlights clinical advances presented at the 2015 Journées Dermatologiques de Paris conference.
- Focuses on autoimmune, inflammatory, and systemic diseases.
- Reviews developments from the past year.
Purpose:
- To summarize the latest clinical advances in autoimmune, inflammatory, and systemic diseases.
- To evaluate new classifications and prognostic factors.
- To present significant clinical trial results.
Summary:
- Discusses updated classifications for systemic lupus erythematosus and systemic sclerosis.
- Examines the application of rituximab in idiopathic thrombocytopenic purpura.
- Covers rituximab's role in maintenance therapy for anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Impact:
- Provides a concise overview of recent progress in managing complex systemic diseases.
- Informs clinicians about emerging diagnostic and therapeutic strategies.
- Facilitates understanding of new treatment paradigms for autoimmune and inflammatory conditions.
Keywords:
Anti-neutrophil cytoplasmic antibodies-associated vasculitisIdiopathic thrombocytopenic purpuraInternal medicineLupus érythémateux systémiqueMédecine internePurpura thrombopénique idiopathiqueSclérodermie systémiqueSystemic lupus erythematosusSystemic sclerosisVascularites associées aux anticorps anticytoplasme des polynucléaires neutrophiles
Related Concept Videos
01:14Myocarditis III: Medical Management
315
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
315
01:17Pericarditis III: Medical Management
500
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
500
01:18Endocarditis III: Medical Management
329
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
329
01:26Mitral Stenosis III: Medical Management
441
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
441
01:21Rheumatic Heart Disease III: Medical Management
487
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
487
01:29Cardiomyopathy V: Interprofessional Care
621
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621